aMoon
Healthcare Venture CapitalRa’anana, IsraelSee on the mapamoon.fund
Health specialist
aMoon is an investment fund focused on HealthTech and life sciences. It invests in early- and late-stage companies developing solutions for unmet medical needs.
- 2
- Portfolio companies on reccy
- 2
- Hiring now
- 13
- Open roles in the portfolio
- Mar 2019
- Latest portfolio round
Hiring now in the portfolio13
Apply on each company's site- Posted 5d ago
Senior Territory Manager - Pain/Peripheral Nerve Stimulation - Kansas City
Bioventus · Kansas City, MO
- Posted 6d ago
Senior Territory Manager - Pain/Peripheral Nerve Stimulation - Oklahoma City
Bioventus · Oklahoma City, OK
- Posted 6d ago
Senior Territory Manager - Pain/Peripheral Nerve Stimulation - Baltimore
Bioventus · Baltimore, MD
- Posted 6d ago
Field Clinical Manager - Peripheral Nerve Stimulation (North New Jersey)
Bioventus · Newark, NJ
- Posted 6d ago
Field Clinical Manager - Peripheral Nerve Stimulation (Jacksonville FL)
Bioventus · Jacksonville, FL
- Posted 10d ago
Senior Territory Manager - Pain/Peripheral Nerve Stimulation - Indianapolis
Bioventus · Indianapolis, IN
- Posted 13d ago
Senior Territory Manager - Pain/Peripheral Nerve Stimulation - Wisconsin
Bioventus · Milwaukee, WI
- Posted 13d ago
Senior Territory Manager - Pain/Peripheral Nerve Stimulation - Salt Lake City
Bioventus · Salt Lake City, UT
Portfolio on reccy2
From company funding recordsTheir companies, round by round
From company funding records- BioventusDurham, North Carolina
Neuromodulation
- Jul 2025Post-IPO Debt · $400M
- Apr 2022Post-IPO Debt · $415M
- Feb 2021Stock Offering · $104M
- Jul 2020Equity Investment · $15M
- Jan 2018Seed · $2.5MLed
- Jan 2018Venture Round
- TheranicaNetanya, Israel
Digital therapeutics · Neuromodulation · Wearables
- Aug 2022Series C · $45M
- Mar 2019Series B · $35MLed
- Jul 2017Series A · $6M
- Sep 2016Seed
Rounds marked Led list aMoon as a lead investor; the rest are the company's other funding.
Recent rounds in the portfolio
- Mar 2019
Theranica · Series B $35MLead
- Jan 2018
Bioventus · Seed $2.5MLead
With Johnson & Johnson Innovation (JJDC Inc.), Peregrine Ventures, Elron Ventures
Portfolio in the news
From the Cortex · last 12 months- Sep 2026Theranica Adds Migraine Prediction to Nerivio
Theranica · Articles | Neurofounders